Proteome Serological Determination of Tumor-Associated Antigens in Melanoma
Michael Forgber, Uwe Trefzer, Wolfram Sterry et al. · 2009
Read Proteome Serological Determination of Tumor-Associated Antigens in Melanoma by Michael Forgber, Uwe Trefzer, Wolfram Sterry et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005199.txt.
Description
Melanoma, the deadliest skin cancer, provokes a strong response from the patient's own immune system. That response leaves antibodies in the blood that flag tumor proteins. Forgber and colleagues used proteome serology in PLOS ONE in 2009 to find those flagged proteins.
The method screens tumor proteins against patient serum to find antigens tied to the cancer. Such antigens can become markers for diagnosis or targets for therapy. Mining the patient's own immune response is a smart shortcut, since the body has already picked out which tumor proteins stand out. For people with this skin cancer, a blood test of that kind could mean fewer scans and less time spent in doubt.
Catalog record
| CREATOR | Michael Forgber, Uwe Trefzer, Wolfram Sterry et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005199